Arbutus Biopharma repurchases 46,000,000 shares for USD 230 million in modified Dutch auction tender offer

Bitget2026/09/30 11:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Arbutus Biopharma expects to repurchase 46,000,000 common shares for cancellation in a modified Dutch auction tender offer.
Preliminary purchase price set at US$ 5.00 per share, implying US$ 230 million in total consideration.
Offer was oversubscribed, with 65,907,215 shares tendered at or below US$ 5.00; estimated proration about 55%.
Roivant Sciences tendered proportionately, keeping its stake near 19.5% following completion of the repurchase.
Shares outstanding expected to fall to about 153,275,907 once the repurchase is completed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arbutus Biopharma Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609300730PRIMZONEFULLFEED9836648) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Arbutus Biopharma repurchases 46,000,000 shares for USD 230 million in modified Dutch auction tender offer

You may also like

Crypto prices